Literature DB >> 24656765

Giant schwannoma of the first metatarsal: a rare entity.

Mohammed Tahir Ansari1, Shishir Rastogi2, Shah Alam Khan3, Chandershekhar Yadav3, Laxman Rijal4.   

Abstract

Schwannomas of osseous origin are rare, and schwannomas of the short tubular bones are even rarer. These benign-looking tumors are difficult to diagnose using imaging alone. However, histopathologic evaluation of a biopsy specimen can establish the diagnosis by identifying Antoni type A and B zones. Curettage and bone grafting will probably be adequate for treatment because malignant changes are unlikely. Large lesions can require en bloc excision and reconstruction. We describe what appears to be only the second case of a schwannoma in the first metatarsal of the foot in a 48-year-old woman. The lesion was poorly contained, with obvious breaks in the cortical shell. The diagnosis was confirmed by pathologic analysis. The lesion was successfully treated with en bloc resection and reconstruction with a nonvascularized fibular graft.
Copyright © 2014 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Schwann cell; bone; fibula; nerve sheath; neurilemmoma; tumor

Mesh:

Year:  2014        PMID: 24656765     DOI: 10.1053/j.jfas.2014.01.014

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  3 in total

1.  Giant schwannoma of the foot: a case report and literature review.

Authors:  Francesco Muratori; Marco De Gori; Francesco Rosario Campo; Leonardo Bettini; Antonio D'Arienzo; Guido Scoccianti; Rodolfo Capanna
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

2.  First-ever intraosseous ancient schwannoma of the proximal ulna successfully treated using the cement technique.

Authors:  Kai Xuan Lim; Karl Wu
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

3.  Benign peripheral nerve sheath tumor of digit versus major-nerve: Comparison of MRI findings.

Authors:  Seul Ki Lee; Jee-Young Kim; Hyang Sook Jeong
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.